Brain Derived Neurotrophic Factor and cognitive markers in subjects with Alzheimer’s disease

Saved in:
Bibliographic Details
Title: Brain Derived Neurotrophic Factor and cognitive markers in subjects with Alzheimer’s disease
Authors: Naybí Prendes Rivero, Levis Verde Corvo, Belkis López González, Iris Dany Carmenate Rodríguez, Nibaldo B Mesa Hernández, María A Robinson Agramonte
Source: Revista Habanera de Ciencias Médicas, Vol 22, Iss 5, Pp e5179-e5179 (2024)
Publisher Information: Universidad de Ciencias Médicas de La Habana, 2024.
Publication Year: 2024
Subject Terms: Medicine (General), factor neurotrófico derivado del cerebro, R5-920, función ejecutiva, enfermedad de alzheimer, memoria episódica, Public aspects of medicine, RA1-1270, deterioro cognitivo leve
Description: Introduction: The brain derived neurotrophic factor is a neurotrophin modulator of cognitive processes. Current studies in Alzheimer’s disease patients show alterations in biomarkers at outlying levels. Objective: To analyze the association between the serum brain-derived neurotrophic factor levels and the cognitive markers in Alzheimer’s disease subjects. Material and Methods: A correlational transversal study was conducted in subjects aged 64 years, distributed into three groups: group 1ː16 controls, group 2ː27 with mild cognitive impairment, and group 3ː21 with Alzheimer’s disease. A neuropsychological test battery, and the immunoenzymatic method (ELISA), Promega Emax Kit were applied to determine the serum brain-derived neurotrophic factor levels. The statistical analysis of data was performed using the one-way ANOVA test, the post-hoc Dunnett´s test and the Pearson’s correlation coefficient (p
Document Type: Article
Language: English
ISSN: 1729-519X
Access URL: https://doaj.org/article/0ef0af1b7c7b42b0babd1b4908e5cfed
Accession Number: edsair.doajarticles..a6ae7d01a2846656bb0b523975ea79eb
Database: OpenAIRE
Description
Abstract:Introduction: The brain derived neurotrophic factor is a neurotrophin modulator of cognitive processes. Current studies in Alzheimer’s disease patients show alterations in biomarkers at outlying levels. Objective: To analyze the association between the serum brain-derived neurotrophic factor levels and the cognitive markers in Alzheimer’s disease subjects. Material and Methods: A correlational transversal study was conducted in subjects aged 64 years, distributed into three groups: group 1ː16 controls, group 2ː27 with mild cognitive impairment, and group 3ː21 with Alzheimer’s disease. A neuropsychological test battery, and the immunoenzymatic method (ELISA), Promega Emax Kit were applied to determine the serum brain-derived neurotrophic factor levels. The statistical analysis of data was performed using the one-way ANOVA test, the post-hoc Dunnett´s test and the Pearson’s correlation coefficient (p
ISSN:1729519X